Outcomes and Predictors of Stimulant Misuse in College Students with and Without ADHD
Overview
Affiliations
In recent years, rates of prescription stimulant misuse have increased among young adults ages 18 to 25 along with increases in dispensing rates of these medications. Preliminary studies suggest that college students with Attention-Deficit Hyperactivity Disorder (ADHD) may be more likely to misuse their stimulant medication than their non-ADHD peers. Research is needed to further explore possible rates, correlates, and outcomes of prescription stimulant misuse among college students with and without ADHD. Data regarding study strategies, psychological functioning, stimulant misuse, and GPA were collected from students from universities within the US ( = 144), showing significantly higher rates of misuse among college students with ADHD. With depression and anxiety entered into the predictive model, inattentive symptoms were the only significant predictor of misuse in the full sample. The present findings have implications for academic interventions aimed at supporting the success of college students with and without ADHD and inform academic outcomes of prescription stimulant misuse.
The Awareness of Methylphenidate and Its Use: Experiences and Perceptions of Medical Students.
Onal B, Bayindir M, Topkarci Y, Dogan A, Oktan B, Yunusoglu O Cureus. 2024; 16(11):e74317.
PMID: 39717319 PMC: 11666070. DOI: 10.7759/cureus.74317.
Adverse Childhood Experiences and Prescription Stimulant Use in Adults: A Systematic Review.
Beatty A, Shepard E, Bickford E, Weyandt L Pharmacy (Basel). 2024; 12(2).
PMID: 38525732 PMC: 10961765. DOI: 10.3390/pharmacy12020052.
Trends in Use of Telemedicine for Stimulant Initiation Among Children and Adults.
Huskamp H, Uscher-Pines L, Raja P, Normand S, Mehrotra A, Busch A Psychiatr Serv. 2024; 75(7):630-637.
PMID: 38239181 PMC: 11216869. DOI: 10.1176/appi.ps.20230421.
Yu R, Goulter N, Godwin J, McMahon R Clin Child Fam Psychol Rev. 2023; 26(4):1008-1024.
PMID: 37819404 DOI: 10.1007/s10567-023-00459-y.
Kasson E, Filiatreau L, Davet K, Kaiser N, Sirko G, Bekele M J Psychoactive Drugs. 2023; 56(3):422-432.
PMID: 37381990 PMC: 10755072. DOI: 10.1080/02791072.2023.2228781.